IVERIC bio
ISEE
ISEE was delisted on the 10th of July, 2023.
162 hedge funds and large institutions have $2.02B invested in IVERIC bio in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 31 closing their positions.
591% more call options, than puts
Call options by funds: $40.2M | Put options by funds: $5.82M
50% more funds holding in top 10
Funds holding in top 10: 8 → 12 (+4)
9% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 57
10% less capital inflows, than outflows
Capital inflows: $207M | Capital outflows: $229M
1.08% less ownership
Funds ownership: 104.83% → 103.75% (-1.1%)
7% less funds holding
Funds holding: 175 → 162 (-13)
39% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$31.9M |
| 2 |
Janus Henderson Group
London,
|
+$21.2M |
| 3 |
Jennison Associates
New York
|
+$21.1M |
| 4 |
TCG Crossover Management
Palo Alto,
California
|
+$11.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$8.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RTW Investments
New York
|
-$112M |
| 2 |
Perceptive Advisors
New York
|
-$18.5M |
| 3 |
Commodore Capital
New York
|
-$14.8M |
| 4 |
Avidity Partners Management
Dallas,
Texas
|
-$7.09M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$6.82M |
ISEE Hedge Fund Activity: Q1 2022 in Review
162 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio (ISEE) for Q1 2022, worth a combined $2.02B — up 0.79% from $2B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of ISEE and 19 opened new positions — a net loss of 12 holders — while 57 trimmed existing stakes and 62 added.
The largest buyer was Morgan Stanley, adding an estimated $31.9M. The largest seller was RTW Investments, exiting entirely with an estimated $112M sold.
- 162 institutional investors held IVERIC bio (ISEE) as of Q1 2022, down from 175 in Q4 2021.
- Funds reported $2.02B of IVERIC bio stock for Q1 2022, up 0.79% quarter-over-quarter.
- 19 funds opened new IVERIC bio positions in Q1 2022 and 31 closed out, a net change of -12 holders.
- The largest IVERIC bio buyer in Q1 2022 was Morgan Stanley, an estimated $31.9M added.
- The largest IVERIC bio seller in Q1 2022 was RTW Investments, an estimated $112M sold.
Based on aggregated 13F filings for Q1 2022.